A "toxic window" study on the hippocampal development of mice offspring exposed to azithromycin at different doses,

Liyi Wei1, Tingting Wang1, Mingcui Luo1

  • 1Department of Obstetric, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, 430071, China.

PubMed
Abstract

Insights

Prenatal azithromycin exposure (PAzE) can harm fetal hippocampal development, particularly at high doses late in pregnancy. This study reveals PAzE-induced toxicity in nerve cells, highlighting risks associated with maternal medication use.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Pharmacology

Background:

  • Azithromycin is a macrolide antibiotic used for mycoplasma infections during pregnancy.
  • Epidemiological studies suggest adverse pregnancy outcomes linked to prenatal azithromycin exposure (PAzE).
  • The specific impact of PAzE on fetal hippocampal development remains unclear.

Purpose of the Study:

  • To investigate the effects of PAzE on fetal hippocampal development.
  • To explore the underlying mechanisms of PAzE-induced toxicity.
  • To assess dose, course, and timing-dependent effects of PAzE.

Main Methods:

  • Pregnant mice were administered azithromycin via gavage at varying doses (50-200 mg/kg/day).
  • Exposure varied in duration (3 consecutive days or single dose) and timing during gestation (GD10-12, GD15-17).
  • Fetal hippocampus development, neuronal markers, glial markers, and signaling pathways were analyzed.

Main Results:

  • PAzE caused morphological damage and dysregulated neuronal proliferation/apoptosis in the fetal hippocampus.
  • Decreased expression of neuronal markers (Snap25, NeuN, PSD95, Map2) and increased glial markers (Iba1, GFAP, S-100β) were observed.
  • Toxicity was most pronounced with high doses, late pregnancy, and multi-course exposure (AZHT), linked to SOX2/Wnt signaling pathway disruption.

Conclusions:

  • PAzE is associated with hippocampal developmental toxicity affecting various nerve cells.
  • The most significant toxicity occurred in the late pregnancy, high-dose, multi-course group (AZHT).
  • Findings support cautious azithromycin use during pregnancy and risk assessment for fetal neurodevelopmental toxicity.

Related Concept Videos